Scripscan:Ambalal Sarabhai Enterprises Ltd
cmp:12
Code:500009
Story:They are the largest manufacturers of vitamin-C. They have a big real estate chunk. At one time, they were a pioneer in this field, and lately they have been tying up with various pharmaceutical companies, on a 50-50 joint venture basis for marketing. It is a turnaround story, and one can expect improvement in their working in time to come.People are running for all these dud stocks, which do not have any merits. Atleast this company has the foundation and the background. They also have the tangible assets and expertise in the field. So at Rs 11-12Rs , this pharmacy appears to be very cheap. It looks like, it can give a good upside.The vitamin-C market has been very volatile. The price fluctuation is very high for the product. So they have been going for JVs, by utilising their infrastructure of the real estate and the personel, and they are trying to come out of that. Ultimately, the expertise of the infrastructure or the manpower will be utilised on a JV basis. We hope that they would be able to do better and turnaround, because we have seen these kind of cases hapenning.Its certainly a stock to keep a close eye on.
Search This Blog(Over 800 companies covered in the blog).
Please note
Archives : Old artciles
Sunday, November 1, 2009
Important Disclaimer&Privacy policy
This blog does not share personal information with third parties nor do we store any information about your visit to this blog other than to analyze and optimize your content and reading experience through the use of cookies.You can turn off the use of cookies at anytime by changing your specific browser settings.This privacy policy is subject to change without notice and was last updated on 20.3.2013. If you have any questions, feel free to contact me directly here: arunsharemarket@gmail.com
Investment in equity shares has its own risks.Sincere efforts have been made to present the right investment perspective.The information contained herein is based on analysis and up on sources that I consider reliable. I,however,do not vouch for the accuracy or the completeness thereof.This material is for personal information and am not responsible for any loss incurred based upon it & take no responsibility whatsoever for any financial profits or loss which may arise from the recommendations above.The stock price projections shown are not necessarily indicative of future price performance.The information herein, together with all estimates and forecasts, can change without notice.
